Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
Journal
-
- The Lancet Rheumatology
-
The Lancet Rheumatology 5 (4), e215-e224, 2023-04
Elsevier BV
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1360017280647582848
-
- ISSN
- 26659913
-
- Data Source
-
- Crossref
- KAKEN